7KY-74289-94650
3 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 934 / CA
- Registered
- 2022-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-05-07
Dose 2 — Pfizer-BioNTech
-
2022-02-06
Registered in v-safe
-
2022-02-06
Dose 3 — Pfizer-BioNTech
-
2022-02-06
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-02-07
-
2022-02-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Nausea · Be unable to work or attend schoolAdult check-in
- 2022-02-10
- 2022-02-22
-
2022-03-01
Survey response — day 21, dose 3MedDRA: Influenza — Feeling: FairFree text: Flu symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-03-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | No |
| 2 | 2021-05-07 | Pfizer-BioNTech | No |
| 3 | 2022-02-06 | Pfizer-BioNTech | No |
Free text
Release 11 — day 21, dose 3
Symptoms: Flu symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release